لماذا تشعر شركات السياحة العلاجية بأزمة رغم استمرار السوق؟

Why do medical-tourism businesses feel under pressure while the market continues?

A blanket claim that Turkish medical tourism has collapsed is not supported by available official data. USHAŞ reports 1,506,442 health-service visitors in 2024 and 1,398,580 in 2025, while reported revenues remained close to US$3.023 billion in both years. Those are sector totals; they do not show the profitability of individual companies.

An individual firm can face pressure when its cost to acquire a patient rises relative to the net value of the case. That is a business hypothesis to test internally, not a conclusion from national statistics. The gap may widen when services compete only on price or when consultation, language support and follow-up are unclear before and after travel.

Audit the full patient journey: source, medical qualifications, informed consent, inclusions, travel, response time, aftercare and complaints. Measure cost per completed case rather than cost per message, and assess clinical outcomes under appropriate medical governance rather than marketing promises. For some markets, local presence or partnership may serve patients better than requiring travel; the decision depends on licensing, demand and clinical design.

In Expand, 7Grounds works on market understanding, localization and communication with medical and legal specialists. The more useful question is not merely “How do we buy more leads?” but “Can patients trust a clear and responsible care journey?”